![]() ![]() This capacity could be better adapted to manufacture more COVID vaccines, which could supply India and the world with cheap doses. The company also owns 145 patents and produces hepatitis B, rotavirus and typhoid vaccines, and is developing vaccines for viral diseases like chikungunya and Zika.Ĭumulatively, Indian vaccine manufacturers including SII, Bharat Biotech, Panacea Biotec, Sanofi Shantha Biotechnics, Biological E, Hester Biosciences and Zydus Cadila have an installed capacity to manufacture 8.2 billion doses of different vaccines every year. "Sure, the focus on other vaccines may have taken a back seat, but it won't be long before we are back to producing vaccines using cutting edge genetic and cell-based technologies," the official added.Īnother major Indian vaccine producer is the Hyderabad-based Bharat Biotech, which produces India's domestically developed Covaxin COVID vaccines. Covishield is what the AstraZeneca COVID vaccine is called in India. "Right now, our focus is ramping up production of Covishield vaccines for the country, which is an emergency," an SII official told DW. Its vaccines are used in around 170 countries for national immunization programs, saving millions of lives throughout the world. It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by SII. ![]() SII makes vaccines against diphtheria, tetanus, pertussis, hepatitis B, measles, mumps and rubella, and ships out more than 1.5 billion vaccine doses annually at affordable prices. ![]() Pune-based SII is the world's largest vaccine manufacturer by volume of doses it has produced and sold globally. There is also concern that as manufacturers play catch-up, the production of other vaccines could be affected. Vaccine shortages continue throughout India, and in parts of the developing world that had depended on Indian production. However, as the pandemic grew out of control at home, Indian authorities were forced to cap exports. India is a world leader in vaccine manufacturing, and Indian pharmaceutical companies supply more than 50% of global demand for different vaccines needed for global immunization problems.īefore COVID surged in India this spring, Indian vaccine manufacturers like the Serum Institute of India (SII) were supplying developing countries with coronavirus vaccine doses via the World Health Organization's COVAX program. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |